MARKET

ICPT

ICPT

Intercept
NASDAQ

Real-time Quotes | Nasdaq Last Sale

96.65
-3.01
-3.02%
After Hours: 96.40 -0.25 -0.26% 17:14 01/24 EST
OPEN
99.86
PREV CLOSE
99.66
HIGH
100.11
LOW
95.91
VOLUME
574.23K
TURNOVER
--
52 WEEK HIGH
131.87
52 WEEK LOW
56.76
MARKET CAP
3.16B
P/E (TTM)
-8.8902
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ICPT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ICPT News

  • Where Will Intercept Pharmaceuticals Be in 5 Years?
  • MotleyFool.com.2d ago
  • 2 Small-Cap Biotech Stocks to Watch in 2020
  • MotleyFool.com.2d ago
  • 2 Mid-Cap Biotech Stocks to Buy Right Now
  • MotleyFool.com.3d ago
  • Intercept 8-K Shows FDA Notified Co. Of Extension For PDUFA Target Action Date To Jun. 26, 2020
  • Benzinga.01/17 13:11

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About ICPT

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.
More

Webull offers Intercept Pharmaceuticals Inc (ICPT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.